Christopher M. Fulkerson

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog Breed”.

Basal and Luminal Molecular Subtypes in Naturally-Occurring Canine Urothelial Carcinoma are Associated with Tumor Immune Signatures and Dog Breed

Bladder Cancer(2021)10.3233/blc-201523

N/A

0DataRank · unranked

11 citations

Deepika Dhawan, Audrey Ruple, José A. Ramos‐Vara, Noah M. Hahn, Sagar M. Utturkar +8 more

Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.22.654354

N/A

0DataRank · unranked

1 citations

Spencer M. Richardson, Leah A. Everitt, Gabrielle J. Knafler, Gavin P. Kinsella, Alyssa L. Walker +14 more

Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0121

N/A

0DataRank · unranked

0 citations

Spencer M. Richardson, Leah A. Everitt, Gabrielle J. Knafler, Alyssa L. Walker, Venetia A. Whiteside +18 more